Development of Halal modified release gliclazide 60 mg tablets by central composite design and production by direct compression
Background: Gliclazide is a second generation sulphonylurea drug used for the treatment of type 2 diabetes mellitus. Commercially available modified release (MR) gliclazide tablet is a once-daily formulation that employs a hydrophilic matrix of a hypromellose for drug release retardant activity. It...
Disimpan dalam:
| Pengarang-pengarang Utama: | , , |
|---|---|
| Format: | Conference or Workshop Item |
| Bahasa: | English |
| Diterbitkan: |
2014
|
| Subjek-subjek: | |
| Capaian Atas Talian: | http://irep.iium.edu.my/38282/ http://irep.iium.edu.my/38282/ http://irep.iium.edu.my/38282/1/ICIP_2014.pdf |
| Penanda-penanda: |
Tambah Penanda
Tiada Penanda, Jadilah orang pertama menanda rekod ini!
|